MedTrace Logo

the Clinical Performance of the Oxysoft Daily Disposable Silicone Hydrogel Soft Contact Lens

NCT03934788 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2019-05-02

No results posted yet for this study

Summary

The objective of this study is to demonstrate that the OxySoft silicone hydrogel soft contact lens could be prescribed as a supportive care for myopes.

Conditions

  • Myopia

Interventions

DEVICE

oxysoft (olifilcon C)

subjects meet certain criteria will be administered randomly oxysoft on both eye for one month on daily wear single use modality.

DEVICE

Si-Hy (olifilcon B)

subjects meet certain criteria will be administered randomly Si-Hy on both eye for one month on daily wear single use modality.

Sponsors & Collaborators

  • Jens Medical Consulting Ltd.

    collaborator UNKNOWN

  • Visco Vision Inc.

    lead INDUSTRY

Principal Investigators

  • Huey Chuan Cheng, MD MSc · Mackay Memorial Hospital

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-09-26
Primary Completion
2018-11-29
Completion
2018-11-29

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03934788 on ClinicalTrials.gov